期刊文献+

2型糖尿病患者血浆P-选择素、sICAM-1、sVCAM-1水平与胰岛素抵抗的关系 被引量:1

下载PDF
导出
摘要 目的:探讨2型糖尿病患者中P选择素及可溶性细胞间黏附分子-1(sI-CAM-1)、可溶性血管细胞黏附分子-1(sVCAM-1)水平的变化与胰岛素抵抗之间的关系,以及P选择素与sICAM-1、sVCAM-1的相关性。方法:采用酶联免疫吸附法测定60例2型糖尿病患者血清可溶性P-选择素(sP-selectin)、可溶性细胞间黏附分子-1(sICAM-1)和可溶性血管细胞黏附分子-1(sVCAM-1)浓度,并与30例健康人(对照组)进行比较。收集糖尿病患者空腹血糖、空腹胰岛素等有关数据,计算胰岛素抵抗指数(IRI),并将其分为A组(胰岛素抵抗组)和B组(非胰岛素抵抗组)。结果:2型糖尿病胰岛素抵抗(A)组、2型糖尿病非胰岛素抵抗(B)组和对照组的血清P-选择素、sICAM-1、sVCAM-1水平均增高,差异具有统计学意义(P<0.05);且A组与B组相比较,A组P-选择素、sICAM-1、sVCAM-1水平亦增高,差异具有统计学意义(P<0.05)。相关分析显示P-选择素sICAM-1、sVCAM-1与胰岛素抵抗指数均呈正相关。结论:P-选择素、sICAM-1和sVCAM-1水平与糖尿病及胰岛素抵抗密切相关;P-选择素、sICAM-1、sVCAM-1可能参与了胰岛素抵抗和2型糖尿病的形成及发展。
作者 李海玲
出处 《中国社区医师(医学专业)》 2011年第33期168-169,共2页
  • 引文网络
  • 相关文献

参考文献7

  • 1Gokulakrishnan K, Deepa R, Mohan , et al.Soluble P - selectin and CD40L levels in sub- jects with prediabetes, diabetes mellitus, and metabolic syndrome - the Chennai Urban Ru- ra! Epidemiology Study. Metabolism, 2006,55 (2) :237 -242.
  • 2Yngen M,Li N, Hjemdahl P, et al. Insulin en- hances platelet activation in vitro. Thromb Res,2001,104(2) :85 -91.
  • 3Roberts CK,Won D,Pruthi S,et ~. Effect of a short- term diet and exercise intervention on oxidative stress, inflammation, MMP - 9, and monocyte chemotactic activity in men with metabolic syndrome factors. Jappl Physiol, 2006.1O0 ( 5 ) 1657 - 1665.
  • 4Murohara T, Parkinson S J, waldman SA, et al. Inhibition of nitrie oxide biosynthesis promotes P- selectin expression in Platelets. Role of Protein kinaseC. Arterioscler Thromb Vasc Bi- ol, 1995,11:2068 - 2075.
  • 5SudieD, Razmara M, Forslund M, et al. High glueose levels enhance platelet activation: in- volvement of multiple mechanisms. Br J Haemato1,2006,133 ( 3 ) :315 - 322.
  • 6Piggot R, Dillon L P, Hominwgay I H, et al. Soluble forms of E - selectin, ICMA - 1 and VCAM - 1 in the supernants of cytokine acti- vated cultured endothelial cell [ J ]. Bioehem Biophy sRes Commun, 1992, 187:584 - 589.
  • 7Richte V, Rassoul F, Wagner 0, et al. Solubl e cell adhesion molecules in patients with hy- perlipid mias and coronary artery disease [ J ]. Atherosclerosis, 1999,147 ( 12 ) :31.

同被引文献7

  • 1Patel TP,Rawal K,Bagchi AK,et al.Insulin resistance:an additional risk factor in the pathogenesis of cardiovasculardisease in type 2 diabetes[J].Heart failure reviews,2016,21(1):11-23.
  • 2Reaven GM,Lithell H,Landsberg L.Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system[J].N Engl J Med,1996,334(6):374-381.
  • 3Mitchell TH,Nolan B,Henry M,et al.Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure[J].Am J Med 102(6):531-535.
  • 4Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistance andβ-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologia,1985,28(7):412-419.
  • 5Cheng C,Daskalakis C.Association of Adipokines with Insulin Resistance,Microvascular Dysfunction,and Endothelial Dysfunction in Healthy Young Adults[J].Mediators of inflammation,2015,2015:594039.
  • 6Ishikawa M,Cooper D,Russell J,et al.Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation[J].Stroke,2003,34(7):1777-1782.
  • 7宋庆桥,胡元会,商秀洋,石洁,吴华芹,曹雪滨,李俊峡.冠心病稳定型心绞痛血瘀证患者tPAI-1、sICAM-1及MMP-9的表达变化[J].中国中医急症,2011,20(9):1377-1380. 被引量:16

引证文献1

;
使用帮助 返回顶部